DK1267924T3 - Immunterapeutiske metoder og sammensætninger - Google Patents
Immunterapeutiske metoder og sammensætningerInfo
- Publication number
- DK1267924T3 DK1267924T3 DK01929778.7T DK01929778T DK1267924T3 DK 1267924 T3 DK1267924 T3 DK 1267924T3 DK 01929778 T DK01929778 T DK 01929778T DK 1267924 T3 DK1267924 T3 DK 1267924T3
- Authority
- DK
- Denmark
- Prior art keywords
- antigen presenting
- presenting cells
- compositions
- relates
- immunotherapeutic methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0007150.6A GB0007150D0 (en) | 2000-03-24 | 2000-03-24 | Immunotherapeutic methods and compositions |
PCT/GB2001/001936 WO2001072277A2 (en) | 2000-03-24 | 2001-03-26 | Immunotherapeutic methods and compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1267924T3 true DK1267924T3 (da) | 2012-05-29 |
Family
ID=9888324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01929778.7T DK1267924T3 (da) | 2000-03-24 | 2001-03-26 | Immunterapeutiske metoder og sammensætninger |
Country Status (13)
Country | Link |
---|---|
US (2) | US20040110695A1 (da) |
EP (1) | EP1267924B1 (da) |
JP (1) | JP2004517031A (da) |
AT (1) | ATE544470T1 (da) |
AU (2) | AU5646101A (da) |
CA (1) | CA2404325C (da) |
DK (1) | DK1267924T3 (da) |
ES (1) | ES2382070T3 (da) |
GB (1) | GB0007150D0 (da) |
NO (1) | NO333157B1 (da) |
NZ (1) | NZ522058A (da) |
PT (1) | PT1267924E (da) |
WO (1) | WO2001072277A2 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0007150D0 (en) * | 2000-03-24 | 2000-05-17 | Lamellar Therapeutics Limited | Immunotherapeutic methods and compositions |
GB0207653D0 (en) * | 2002-04-03 | 2002-05-15 | Lamellar Therapeutics Ltd | Methods of using lamellar bodies for therapeutic purposes |
CA2515369C (en) * | 2003-02-06 | 2015-03-31 | Cerus Corporation | Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof |
US11324698B2 (en) * | 2003-08-28 | 2022-05-10 | Vgsk Technologies, Inc. | Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal |
GB0322448D0 (en) | 2003-09-25 | 2003-10-29 | Lamellar Therapeutics Ltd | Using lamellar bodies to modify linear biological macro molecules |
PL1667693T3 (pl) * | 2003-09-25 | 2015-12-31 | Lamellar Biomedical Ltd | Kompozycje i sposoby wykorzystywania ciał blaszkowatych do celów terapeutycznych |
DE602005009535D1 (de) * | 2004-07-07 | 2008-10-16 | Statens Seruminstitut | Von adjuvans-formulierungen auf lipid-basis unter verwendung von glykolipiden |
US7465312B2 (en) | 2006-05-02 | 2008-12-16 | Green Medical, Inc. | Systems and methods for treating superficial venous malformations like spider veins |
WO2007130465A2 (en) | 2006-05-02 | 2007-11-15 | Green Medical, Inc. | Systems and methods for treating superficial venous malformations like spider veins |
WO2011002239A2 (ko) * | 2009-07-01 | 2011-01-06 | 주식회사이언메딕스 | 포유류의 유핵세포에서 유래된 마이크로베시클 및 이의 용도 |
KR101232377B1 (ko) | 2010-07-01 | 2013-02-13 | 주식회사이언메딕스 | 세포의 원형질체에서 유래한 마이크로베시클 및 이의 용도 |
WO2015021390A2 (en) | 2013-08-08 | 2015-02-12 | The Regents Of The University Of California | Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis |
WO2015084677A1 (en) | 2013-12-02 | 2015-06-11 | Arytha Biosciences, Llc | Toxoid preparation and uses thereof |
WO2015143295A2 (en) | 2014-03-20 | 2015-09-24 | The Regents Of The University Of California | Hydrogel compositions containing toxin-absorbing or binding nanoparticles and uses thereof |
WO2015187502A1 (en) | 2014-06-02 | 2015-12-10 | Cellics Therapeutics, Inc. | Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders |
US10434070B2 (en) | 2015-01-02 | 2019-10-08 | Cellics Therapeutics, Inc. | Use of nanoparticles coated with red blood cell membranes to enable blood transfusion |
WO2016176041A1 (en) | 2015-04-29 | 2016-11-03 | The Regents Of The University Of California | Detoxification using nanoparticles |
EP3632410A1 (en) | 2018-10-05 | 2020-04-08 | Lamellar Biomedical Limited | Lipidic polynucleotide carriers for cellular delivery |
EP3692984A1 (en) | 2019-02-08 | 2020-08-12 | Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts | Annexin-coated particles |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5925375A (en) * | 1987-05-22 | 1999-07-20 | The Liposome Company, Inc. | Therapeutic use of multilamellar liposomal prostaglandin formulations |
US5403592A (en) * | 1987-08-25 | 1995-04-04 | Macnaught Pty Limited | Lubricant composition for rheumatism |
US5006343A (en) * | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
FR2645878B1 (fr) * | 1989-04-17 | 1994-02-25 | Institut Nal Sante Recherc Medic | Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes |
US5088499A (en) * | 1989-12-22 | 1992-02-18 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
ATE164230T1 (de) * | 1991-05-29 | 1998-04-15 | Baxter Int | 4verfahren und zusammensetzungen zur vorbeugung, diagnose und behandlung seröser entzündungen und damit verbundener störungen |
JPH05339169A (ja) * | 1992-03-03 | 1993-12-21 | Dai Ichi Seiyaku Co Ltd | 経口ワクチン |
WO1997003703A1 (en) * | 1995-07-21 | 1997-02-06 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
US5543152A (en) * | 1994-06-20 | 1996-08-06 | Inex Pharmaceuticals Corporation | Sphingosomes for enhanced drug delivery |
US5462752A (en) * | 1994-07-28 | 1995-10-31 | Prp, Inc. | Inhibition of platelet binding |
US5643599A (en) * | 1995-06-07 | 1997-07-01 | President And Fellows Of Harvard College | Intracellular delivery of macromolecules |
ES2357960T3 (es) * | 1997-05-08 | 2011-05-04 | Oncothyreon Inc. | Procedimiento para generar células t activadas y células presentadoras de antígenos pulsadas con antígenos. |
GB9807298D0 (en) * | 1998-04-03 | 1998-06-03 | Britannia Pharmaceuticals Ltd | Medicament |
EP0976403A1 (en) * | 1998-07-30 | 2000-02-02 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Adjuvant comprising pulmonary surfactant |
US6290987B1 (en) * | 1998-09-27 | 2001-09-18 | Generex Pharmaceuticals, Inc. | Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids |
US6193997B1 (en) * | 1998-09-27 | 2001-02-27 | Generex Pharmaceuticals Inc. | Proteinic drug delivery system using membrane mimetics |
GB0007150D0 (en) * | 2000-03-24 | 2000-05-17 | Lamellar Therapeutics Limited | Immunotherapeutic methods and compositions |
GB0207653D0 (en) * | 2002-04-03 | 2002-05-15 | Lamellar Therapeutics Ltd | Methods of using lamellar bodies for therapeutic purposes |
GB0322448D0 (en) * | 2003-09-25 | 2003-10-29 | Lamellar Therapeutics Ltd | Using lamellar bodies to modify linear biological macro molecules |
-
2000
- 2000-03-24 GB GBGB0007150.6A patent/GB0007150D0/en not_active Ceased
-
2001
- 2001-03-26 AT AT01929778T patent/ATE544470T1/de active
- 2001-03-26 AU AU5646101A patent/AU5646101A/xx active Pending
- 2001-03-26 DK DK01929778.7T patent/DK1267924T3/da active
- 2001-03-26 PT PT01929778T patent/PT1267924E/pt unknown
- 2001-03-26 EP EP01929778A patent/EP1267924B1/en not_active Expired - Lifetime
- 2001-03-26 JP JP2001570238A patent/JP2004517031A/ja active Pending
- 2001-03-26 NZ NZ522058A patent/NZ522058A/en not_active IP Right Cessation
- 2001-03-26 US US10/239,576 patent/US20040110695A1/en not_active Abandoned
- 2001-03-26 CA CA2404325A patent/CA2404325C/en not_active Expired - Lifetime
- 2001-03-26 WO PCT/GB2001/001936 patent/WO2001072277A2/en active IP Right Grant
- 2001-03-26 ES ES01929778T patent/ES2382070T3/es not_active Expired - Lifetime
- 2001-03-26 AU AU2001256461A patent/AU2001256461B2/en not_active Ceased
-
2002
- 2002-09-24 NO NO20024571A patent/NO333157B1/no not_active IP Right Cessation
-
2006
- 2006-07-24 US US11/491,177 patent/US20080069866A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NZ522058A (en) | 2005-05-27 |
WO2001072277A3 (en) | 2002-06-13 |
EP1267924A2 (en) | 2003-01-02 |
US20080069866A1 (en) | 2008-03-20 |
CA2404325C (en) | 2012-06-12 |
AU2001256461B2 (en) | 2005-06-30 |
CA2404325A1 (en) | 2001-10-04 |
ES2382070T3 (es) | 2012-06-05 |
PT1267924E (pt) | 2012-05-24 |
AU5646101A (en) | 2001-10-08 |
ATE544470T1 (de) | 2012-02-15 |
JP2004517031A (ja) | 2004-06-10 |
WO2001072277A2 (en) | 2001-10-04 |
NO20024571L (no) | 2002-10-14 |
GB0007150D0 (en) | 2000-05-17 |
EP1267924B1 (en) | 2012-02-08 |
NO20024571D0 (no) | 2002-09-24 |
US20040110695A1 (en) | 2004-06-10 |
NO333157B1 (no) | 2013-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1267924T3 (da) | Immunterapeutiske metoder og sammensætninger | |
PT2351579T (pt) | Vacinas polipeptídicas para proteção ampla contra linhagens meningocócicas hipervirulentas | |
NZ331651A (en) | BSW17 peptide immunogens for vaccination against and treatment of allergy | |
IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
NO973250L (no) | Preparater for avlevering av antigener | |
WO2005037190A3 (en) | Multiplex vaccines | |
EP0804158A4 (en) | PREPARATIONS AND METHOD FOR TRIGGERING CTL IMMUNITY | |
TR200002930T2 (tr) | Kolaylaştırıcı kompozisyonlar | |
HK1039749A1 (en) | Use of expressions of ctl and t-helper lymph cellsin vaccination | |
DK1104306T3 (da) | Præparater af CpG- og saponinadjuvanser og fremgangsmåder til anvendelse deraf | |
HK1052629A1 (en) | Proteosome influenza vaccine | |
ES2177927T3 (es) | Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico. | |
ATE419870T1 (de) | Neuer immunogener komplex | |
EP0859625A4 (en) | COMPOSITION AND METHODS FOR ENHANCING IMMUNE RESPONSES DUE TO ANTIGEN PRESENTING CELLS | |
AU2002309259A1 (en) | Improved polysaccharide and glycoconjugate vaccines_____________ | |
WO2004030616A3 (en) | Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES | |
AU6078399A (en) | Ligand presenting assembly (lpa), method of preparation and uses thereof | |
ATE385809T1 (de) | Saponin-zusammensetzungen und deren verwendung | |
WO1999047102A3 (en) | Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby | |
WO2002036160A3 (es) | Método de obtención de estructuras antigénicas que potencian la reactividad cruzada específica | |
BR9905780A (pt) | Antìgenos vacinais de leptospira para prevenção da laptospirose | |
MX9708226A (es) | Vacunas que contienen una saponina y un esterol. |